Abstract:
Benzenesulfonamides of formula (I), in which W is OR1, NR2OR1, NRARB, NR2NRARB, or NR2(CH2)2-4NRARB and the other variables as defined in the claims, are inhibitors of MEK and are effective in the treatment of proliferative diseases, cancer, stroke, heart failure, xenograft rejection, arthritis, cystic fibrosis, hepatomegaly, cardiomegaly, Alzheimer's disease, complications of diabetes, septic shock, and viral infection.
Type:
Grant
Filed:
July 2, 2001
Date of Patent:
August 27, 2002
Assignee:
Warner-Lambert Company
Inventors:
Stephen Douglas Barrett, Haile Tecle, Richard John Booth